{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:17:38Z","timestamp":1787167058097,"version":"build-2736575974"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T00:00:00Z","timestamp":1527465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Dysregulation of the circadian clock machinery is a critical mechanism in the pathogenesis of fibrosis. This study aimed to investigate whether the antifibrotic effect of melatonin is associated with attenuation of circadian clock pathway disturbances in mice treated with carbon tetrachloride (CCl\n                    <jats:sub>4<\/jats:sub>\n                    ) and in human hepatic stellate cells line LX2. Mice received CCl\n                    <jats:sub>4<\/jats:sub>\n                    5 \u03bcL\/g body weight i.p. twice a week for 4 or 6 weeks. Melatonin was given at 5 or 10 mg\/kg\/day i.p., beginning 2 weeks after the start of CCl\n                    <jats:sub>4<\/jats:sub>\n                    administration. Treatment with CCl\n                    <jats:sub>4<\/jats:sub>\n                    resulted in fibrosis evidenced by the staining of \u03b1-smooth muscle actin (\u03b1-SMA) positive cells and a significant decrease of peroxisome proliferator-activated receptor (PPAR\u03b1) expression. CCl\n                    <jats:sub>4<\/jats:sub>\n                    led to a lower expression of brain and muscle Arnt-like protein 1 (BMAL1), circadian locomotor output cycles kaput (CLOCK), period 1\u20133 (PER1, 2, and 3), cryptochrome 1 and 2 (CRY1 and 2) and the retinoic acid receptor-related orphan receptor (ROR\u03b1). The expression of the nuclear receptor REV-ERB\u03b1 showed a significant increase. Melatonin significantly prevented all these changes. We also found that melatonin (100 or 500 \u03bcM) potentiated the inhibitory effect of REV-ERB ligand SR9009 on \u03b1-SMA and collagen1 expression and increased the expression of PPAR\u03b1 in LX2 cells. Analysis of circadian clock machinery revealed that melatonin or SR9009 exposure upregulated BMAL1, CLOCK, PER2, CRY1, and ROR\u03b1 expression, with a higher effect of combined treatment. Findings from this study give new insight into molecular pathways accounting for the protective effect of melatonin in liver fibrosis.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2018.00556","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T04:30:13Z","timestamp":1527481813000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["RETRACTED: Melatonin Attenuates Dysregulation of the Circadian Clock Pathway in Mice With CCl4-Induced Fibrosis and Human Hepatic Stellate Cells"],"prefix":"10.3389","volume":"9","author":[{"given":"B\u00e1rbara","family":"Gonz\u00e1lez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana I.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"San-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ortiz","family":"de Urbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gonz\u00e1lez-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Tu\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1600-079X.2011.00910.x","article-title":"Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.","volume":"51","author":"Carbajo-Pescador","year":"2011","journal-title":"J. Pineal Res."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/653017","article-title":"PPARs integrate the mammalian clock and energy metabolism.","volume":"2014","author":"Chen","year":"2014","journal-title":"PPAR Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1872-034X.2010.00695.x","article-title":"Loss of clock gene mPer2 promotes liver fibrosis induced by carbon tetrachloride.","volume":"40","author":"Chen","year":"","journal-title":"Hepatol. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.etp.2011.12.007","article-title":"Deletion of clock gene Per2 exacerbates cholestatic liver injury and fibrosis in mice.","volume":"65","author":"Chen","year":"2013","journal-title":"Exp. Toxicol. Pathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.febslet.2010.03.019","article-title":"Altered circadian rhythm of the clock genes in fibrotic livers induced by carbon tetrachloride.","volume":"584","author":"Chen","year":"","journal-title":"FEBS Lett."},{"key":"B6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2353\/ajpath.2009.080430","article-title":"The protective role of Per2 against carbon tetrachloride-induced hepatotoxicity.","volume":"174","author":"Chen","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1600-079X.2010.00787.x","article-title":"Melatonin prevents the decreased activity of antioxidant enzymes and activates nuclear erythroid 2-related factor 2 signaling in an animal model of fulminant hepatic failure of viral origin.","volume":"49","author":"Crespo","year":"2010","journal-title":"J. Pineal Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-079X.2010.00787.x","article-title":"Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis induced by carbon tetrachloride in mice.","volume":"166","author":"Crespo","year":"2015","journal-title":"Transl. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.immuni.2014.02.002","article-title":"Circadian clock proteins and immunity.","volume":"40","author":"Curtis","year":"2014","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1146\/annurev-physiol-021909-135821","article-title":"The mammalian circadian timing system: organization and coordination of central and peripheral clocks.","volume":"72","author":"Dibner","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis.","volume":"63","author":"Francque","year":"2015","journal-title":"J. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/biof.1342","article-title":"Inhibition of the SphK1\/S1 signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells.","volume":"43","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"","journal-title":"Biofactors"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00579","article-title":"Sphingosine 1-phosphate signaling as a target in hepatic fibrosis therapy.","volume":"8","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10911-011-9222-4","article-title":"Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer.","volume":"16","author":"Hill","year":"2011","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2131\/jts.35.673","article-title":"Circadian modulation of hepatic transcriptome in transgenic rats expressing human growth hormone.","volume":"35","author":"Hirao","year":"2010","journal-title":"J. Toxicol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/hmg\/ddl207","article-title":"Molecular components of the mammalian circadian clock.","volume":"15","author":"Ko","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1600-079X.2012.00995.x","article-title":"Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin.","volume":"53","author":"Laliena","year":"2012","journal-title":"J. Pineal Res."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129743","article-title":"Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis in mice through inhibition of hepatic stellate cell activation.","volume":"10","author":"Lan","year":"2015","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1002\/hep.27049","article-title":"Novel role of nuclear receptor Rev-erb\u03b1 in hepatic stellate cell activation: potential therapeutic target for liver injury.","volume":"59","author":"Li","year":"2014","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.000773","article-title":"CLOCK phosphorylation by AKT regulates its nuclear accumulation and circadian gene expression in peripheral tissues.","author":"Luciano","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-83","article-title":"Bioinformatics analysis of transcriptional regulation of circadian genes in rat liver.","volume":"15","author":"Nguyen","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1101\/gad.237081.113","article-title":"The circadian clock regulates rhythmic activation of the NRF2\/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis.","volume":"28","author":"Pekovic-Vaughan","year":"2014","journal-title":"Genes Dev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ.","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0092-8674(02)00825-5","article-title":"The orphan nuclear receptor rev-erb\u03b1 controls circadian transcription within the positive limb of the mammalian circadian oscillator.","volume":"110","author":"Preitner","year":"2002","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1147.e5","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b2, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening.","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038985","article-title":"Divergent roles of clock genes in retinal and suprachiasmatic nucleus circadian oscillators.","volume":"7","author":"Ruan","year":"2012","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.biochem.71.090501.142857","article-title":"Metabolism and the control of circadian rhythms.","volume":"71","author":"Rutter","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s10495-006-0090-0","article-title":"N-acetyl-cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure.","volume":"11","author":"San-Miguel","year":"2006","journal-title":"Apoptosis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jpi.12247","article-title":"Melatonin inhibits autophagy and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis.","volume":"59","author":"San-Miguel","year":"2015","journal-title":"J. Pineal Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/jpi.12271","article-title":"Melatonin suppresses activation of hepatic stellate cells through ROR\u03b1 mediated inhibition of 5-lipoxygenase.","volume":"59","author":"Shajari","year":"2015","journal-title":"J. Pineal Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature11030","article-title":"Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.","volume":"485","author":"Solt","year":"2012","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biocel.2016.11.007","article-title":"Rev-erb agonist and TGF\u03b2 similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic phenotype.","volume":"81","author":"Thomes","year":"2016","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3945\/jn.109.105353","article-title":"Quercetin administration ameliorates pulmonary complications of cirrhosis in rats.","volume":"139","author":"Tieppo","year":"2009","journal-title":"J. Nutr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jcf.2006.12.007","article-title":"Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis.","volume":"6","author":"Touw","year":"2007","journal-title":"J. Cyst. Fibros."},{"key":"B35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bcp.2015.06.010","article-title":"Anti-proliferative actions of a synthetic REV-ERB\u03b1,\u03b2 agonist in breast cancer cells.","volume":"96","author":"Wang","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4137\/BCBCR.S9673","article-title":"Oscillation of clock and clock controlled genes induced by serum shock in human breast epithelial and breast cancer cells: regulation by melatonin.","volume":"6","author":"Xiang","year":"2012","journal-title":"Basic Clin. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1126\/science.1059542","article-title":"Molecular mechanisms of the biological clock in cultured fibroblasts.","volume":"292","author":"Yagita","year":"2001","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.2174\/09298673113209990136","article-title":"Hepatic PPARs: their role in liver physiology, fibrosis and treatment.","volume":"20","author":"Zardi","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29878","article-title":"The hepatic BMAL1\/AKT\/Lipogenesis axis protects against alcoholic liver disease via promoting PPAR\u03b1 pathway.","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1126\/science.aab3021","article-title":"Discrete functions of nuclear receptor Rev-erb\u03b1 couple metabolism to the clock.","volume":"348","author":"Zhang","year":"2015","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"8625","DOI":"10.18632\/oncotarget.7065","article-title":"Evolving roles of circadian rhythms in liver homeostasis and pathology.","volume":"23","author":"Zhou","year":"2016","journal-title":"Oncotarget"}],"updated-by":[{"DOI":"10.3389\/fphar.2023.1252194","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"record-id":"46438"},{"DOI":"10.3389\/fphar.2023.1252194","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2018.00556\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T12:58:35Z","timestamp":1712321915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2018.00556\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,28]]},"references-count":41,"alternative-id":["10.3389\/fphar.2018.00556"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00556","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,28]]},"article-number":"556"}}